Verastem, Inc.
USD3.82
+0.04 (+1.06%)
CEO
Daniel W. Paterson
IPO Date
2012-01-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.87
Prev. Close
$3.78
Day Low
$3.75
Day High
$3.87
52W Low
$3.43
52W High
$11.25
Market Cap
$0.26B
Volume
2.67M
| -1.4 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -152.3% | -58.4% | 0.72 | 5.45 | -2.1 |
| 31 Dec 2022 | FY | 100.0% | -2843.3% | -155.8% | -77.7% | 0.57 | 4.29 | -1.0 |
| 31 Dec 2021 | FY | 100.0% | -3468.1% | -81.3% | -65.5% | 0.04 | 5.69 | -5.0 |
| 31 Dec 2020 | FY | 61.9% | -76.5% | -58.8% | -43.9% | 0.20 | 8.48 | -4.8 |
| 31 Dec 2019 | FY | 83.9% | -854.8% | -2079.9% | -102.9% | 14.99 | 2.84 | -0.7 |
| 31 Dec 2018 | FY | 97.8% | -271.1% | -58.3% | -26.1% | 0.97 | 6.83 | -3.2 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -117.5% | -75.5% | 0.26 | 5.13 | -1.7 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -50.4% | -43.6% | 0.00 | 7.40 | -1.1 |
| -4.9 |
| 30 Sept 2025 | Q3 | 85.1% | -876.3% | 634.5% | -55.7% | -5.76 | 2.58 | -1.6 |
| 30 Jun 2025 | Q2 | 79.1% | -1213.6% | -71.9% | -13.2% | 2.35 | 3.46 | -2.6 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | 160.6% | -39.6% | -2.37 | 3.50 | -1.6 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | 223.4% | -63.6% | -1.46 | 3.07 | -0.8 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -74.4% | -19.0% | 1.29 | 3.23 | -1.3 |
| 30 Jun 2024 | Q2 | 100.0% | -82.6% | -20.6% | -7.8% | 1.05 | 3.28 | -2.6 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -73.3% | -27.4% | 0.91 | 4.40 | -2.3 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -47.7% | -18.3% | 0.72 | 5.45 | -2.0 |